You are here:
GAVI Request for Proposal for “Evaluation of Pneumococcal Conjugate Vaccine (PCV) Effectiveness in Asia”
The GAVI Alliance (GAVI) seeks to commission targeted assessments of the effectiveness of GAVI supported use of pneumococcal conjugate vaccines (PCV) in Asia. The intent of the PCV assessment is to monitor the effectiveness of PCV in early adopting GAVI-eligible countries in Asia. Outcomes of interest include pneumococcal serotype replacement and reductions in any of the following: disease transmission, morbidity, mortality, inequity, and social and financial risk.
The selected Service Provider will work with GAVI, country institutions and technical experts to design and implement PCV effectiveness assessment activities in at least one GAVI-eligible Asian country and to regularly communicate progress and findings to key stakeholders including Ministries of Health, country institutions and the GAVI Alliance, to support real time use of the findings and continued programmatic improvements where applicable.
Most of GAVI’s procurement is managed through UNICEF’s and the Pan American Health Organization’s (PAHO) procurement services.
For more information, visit
UNICEF Procurement Services and PAHO Procurement.
© GAVI Alliance 2013
modal window here